Join to View Full Profile
115 Norwood Park S Ste 202Norwood, MA 02062
Phone+1 781-725-0505
Dr. Eliades is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Chief Residency, Dermatology, 2019 - 2020- New York Presbyterian Hospital (Cornell Campus)Residency, Dermatology, 2017 - 2020
Beth Israel Deaconess Medical CenterInternship, Transitional Year, 2016 - 2017
Tufts University School of MedicineClass of 2016, MD, Research Honors
Boston CollegeBS, Biology, 2007 - 2011
Certifications & Licensure
MA State Medical License 2021 - 2025
NY State Medical License 2020 - 2025
RI State Medical License 2021 - 2022
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Distinguished Housestaff Award NewYork Weill Cornell Medical Center Alumni Council, 2019
- William Dameshek Undergraduate Research Award Tufts University School of Medicine, 2016
- Albert M. Kligman Travel Fellowship Society for Investigative Dermatology, 2015
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsLitigation Arising From Minimally Invasive Cosmetic Procedures: A Review of the Literature.Brian P. Hibler, Philip J Eliades, Karen C. Kagha, Mathew M. Avram
Dermatologic Surgery. 2021-08-18 - 11 citationsUse of Etanercept in a Series of Pediatric Patients With Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis Spectrum DiseasePhilip Eliades, Maira Fonseca, Joanna Harp
JAMA Dermatology. 2020-08-01 - 45 citationsHigh MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.Philip Eliades, Brian J. Abraham, Zhenyu Ji, David Miller, Camilla L. Christensen
The Journal of Investigative Dermatology. 2018-07-01
Journal Articles
- Oncogene-directed small molecule inhibitors for the treatment of cutaneous melanomaEliades P, Flaherty K, Tsao H, Melanoma Management, 5/2015
Professional Memberships
- Member
- Women’s Dermatologic SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
